OUTCOMES OF DIGOXIN VS. BETA BLOCKER IN ATRIAL FIBRILLATION: REPORT FROM ESC–EHRA EORP AF LONG-TERM GENERAL REGISTRY

University of Belgrade, Universitaire Trousseau, University of Modena and Reggio Emilia, University of Murcia, University of Liverpool, Clinical Center of Serbia, Aalborg University, Uppsala University

The research investigates the outcomes of digoxin therapy in atrial fibrillation patients, highlighting the potential increased risk of all-cause mortality associated with digoxin compared to beta-blockers. It discusses the implications of concurrent health conditions and treatment choices on patient outcomes. The findings contribute to the ongoing debate regarding the safety of digoxin in AF management, emphasizing the need for careful consideration of patient profiles when prescribing.